0001437749-23-033315.txt : 20240108 0001437749-23-033315.hdr.sgml : 20240108 20231201063027 ACCESSION NUMBER: 0001437749-23-033315 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231201 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BioCardia, Inc. CENTRAL INDEX KEY: 0000925741 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 232753988 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 320 SOQUEL WAY CITY: SUNNYVALE STATE: CA ZIP: 94085 BUSINESS PHONE: 650-226-0123 MAIL ADDRESS: STREET 1: 320 SOQUEL WAY CITY: SUNNYVALE STATE: CA ZIP: 94085 FORMER COMPANY: FORMER CONFORMED NAME: Tiger X Medical, Inc. DATE OF NAME CHANGE: 20110616 FORMER COMPANY: FORMER CONFORMED NAME: Cardo Medical, Inc. DATE OF NAME CHANGE: 20081027 FORMER COMPANY: FORMER CONFORMED NAME: CLICKNSETTLE COM INC DATE OF NAME CHANGE: 20000823 CORRESP 1 filename1.htm bcda20231129_corresp.htm

 

BioCardia, Inc.

320 Soquel Way

Sunnyvale, California 94085

 

December 1, 2023

 

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Cindy Polynice

 

 

Re:

BioCardia, Inc.
 

Registration Statement on Form S-3
 

File No. 333-275099

 

 

Acceleration Request

Requested Date:             December 5, 2023

Requested Time:            4:30 p.m., Eastern Time

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, BioCardia, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-275099) (the “Registration Statement”) be declared effective at the “Requested Date” and “Requested Time” set forth above, or as soon thereafter as practicable, or at such later time as the Company or its counsel may orally request via telephone call to the staff of the Division of Corporation Finance of the Securities and Exchange Commission. Once the Registration Statement has been declared effective, please orally confirm that event with the Company’s counsel, Wilson Sonsini Goodrich & Rosati, P.C., by calling Austin March at (512) 338-5410.

 

[Signature page follows]

 

 
 

 

 

Sincerely, 

 
     
  BioCardia, Inc.  

 

 

 

 

 

/s/ Peter Altman

 
  Peter Altman  
 

President and Chief Executive Officer and

Director

  

 

  cc: 

David McClung, BioCardia, Inc.
   

Michael J. Danaher, Wilson Sonsini Goodrich & Rosati, P.C.
   

Austin D. March, Wilson Sonsini Goodrich & Rosati, P.C.